 |
recombinant humanized anti-interleukin 13 (IL-13) monoclonal antibody |
|---|---|
| Trade Name | |
| Orphan Indication | Eosinophilic esophagitis Eosinophilic esophagitis |
| USA Market Approval | USA |
| USA Designation Date | 2015-02-11 00:00:00 |
| Sponsor | Celgene Corporation;3033 Science Park Road, Suite 300;San Diego, California, 92121 |
Learn more about: